GlassScriptPhysician profile
Kunal Patel
NPI 1376960591
$4,496.22
in general payments reported to CMS, 2019-2025
19 companies · $277 in 2025
The $277 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,701 · 2020: $320 · 2021: $384 · 2022: $309 · 2023: $79.56 · 2024: $425 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $782.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,115.11 | 2019 | |
| Boston Scientific Corporation | $512.20 | 2019-2024 | Watchman Flx |
| Amarin Pharma, INC. | $480.92 | 2019-2023 | |
| Amgen INC. | $430.44 | 2019-2025 | Repatha, Repatha |
| Nevro Corp. | $183.23 | 2019 | |
| Novartis Pharmaceuticals Corporation | $169.23 | 2021-2025 | |
| Esperion Therapeutics, INC. | $106.99 | 2021-2024 | Nexletol |
| Biobeat USA INC. | $100.00 | 2024 | Bb-613 Bpm Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $92.47 | 2019 | |
| Inspire Medical Systems, INC. | $56.58 | 2024-2025 | Inspire |
| Philips North America LLC | $43.86 | 2025 | Mcot |
| Pfizer INC. | $42.75 | 2020-2022 | |
| Althera Pharmaceuticals LLC | $30.23 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $29.80 | 2019-2022 | |
| Cvrx, INC. | $25.00 | 2024 | Barostim Neo System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $22.84 | 2024 | Corevalve Evolut R |
| Kestra Medical Technology Services, INC. | $22.16 | 2023 | Assure Wcd |
| Novo Nordisk INC | $18.35 | 2025 | Ozempic, Rybelsus |
| Regeneron Healthcare Solutions, INC. | $14.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kunal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.